Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of JAG1 mRNA | decreases expression | 19933214
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of JAG1 mRNA | increases expression | 20406850
|
D000111 |
Acetylcysteine |
Acetylcysteine results in decreased expression of JAG1 mRNA | decreases expression | 16084531
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of JAG1 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of JAG1 mRNA | affects expression | 16483693
|
C015001 |
arsenite |
arsenite results in decreased expression of JAG1 mRNA | decreases expression | 18633435
|
C015001 |
arsenite |
arsenite results in decreased expression of JAG1 protein | decreases expression | 18633435
|
C015001 |
arsenite |
[arsenite results in decreased expression of JAG1 protein] which results in decreased expression of HES1 mRNA | decreases expression | 18633435
|
C015001 |
arsenite |
JAG1 protein inhibits the reaction [arsenite results in decreased expression of IVL mRNA] | decreases expression|decreases reaction | 18633435
|
C015001 |
arsenite |
JAG1 protein inhibits the reaction [arsenite results in decreased expression of KRT10 mRNA] | decreases expression|decreases reaction | 18633435
|
C015001 |
arsenite |
tyrphostin AG 1478 inhibits the reaction [arsenite results in decreased expression of JAG1 mRNA] | decreases expression|decreases reaction | 18633435
|
C015001 |
arsenite |
tyrphostin AG 1478 inhibits the reaction [arsenite results in decreased expression of JAG1 protein] | decreases expression|decreases reaction | 18633435
|
D001205 |
Ascorbic Acid |
Ascorbic Acid results in decreased expression of JAG1 mRNA | decreases expression | 15305145
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of JAG1 mRNA | increases expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of JAG1 mRNA | decreases expression | 20713471
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in decreased expression of JAG1 mRNA | decreases expression | 17720352
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of JAG1 mRNA | increases expression | 20106945
|
D004391 |
Dust |
Dust results in increased expression of JAG1 mRNA | increases expression | 15735009
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of JAG1 mRNA | decreases expression | 16084531
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of JAG1 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of JAG1 mRNA | increases expression | 19619570
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of JAG1 mRNA | decreases expression | 17557909
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of JAG1 gene | increases mutagenesis | 16724327
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of JAG1 mRNA | increases expression | 18035473
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of JAG1 mRNA | increases expression | 16510598
|
C106014 |
gedunin |
gedunin results in decreased expression of JAG1 mRNA | decreases expression | 17010675
|
C029424 |
hydrazine |
hydrazine results in decreased expression of JAG1 mRNA | decreases expression | 15282401
|
C533894 |
LG 100815 |
LG 100815 results in increased expression of JAG1 mRNA | increases expression | 16951191
|
D008466 |
Mechlorethamine |
Mechlorethamine results in increased expression of JAG1 mRNA | increases expression | 17107856
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of JAG1 mRNA | decreases expression | 20713471
|
C001478 |
N(6)-(delta(2)-isopentenyl)adenine |
N(6)-(delta(2)-isopentenyl)adenine results in increased expression of JAG1 mRNA | increases expression | 16129123
|
C419410 |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 mRNA | decreases expression | 18633435
|
C419410 |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 protein | decreases expression | 18633435
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in increased expression of JAG1 mRNA | increases expression | 16951191
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in increased expression of JAG1 mRNA | affects cotreatment|increases expression | 19059307
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in increased expression of JAG1 mRNA | affects cotreatment|increases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of JAG1 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of JAG1 mRNA | decreases expression | 20106945 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of JAG1 mRNA | decreases expression | 19933214
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of JAG1 mRNA | increases expression | 16214954
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of JAG1 mRNA | increases expression | 16917069
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in increased expression of JAG1 mRNA | increases expression | 17951470
|
C050414 |
tripterine |
tripterine results in decreased expression of JAG1 mRNA | decreases expression | 17010675
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 inhibits the reaction [arsenite results in decreased expression of JAG1 mRNA] | decreases expression|decreases reaction | 18633435
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 inhibits the reaction [arsenite results in decreased expression of JAG1 protein] | decreases expression|decreases reaction | 18633435
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.23 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.54 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.25 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.63 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.45 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.45 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.45 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
9.45 | 17638652 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.30 | 6695378 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
10.30 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
10.30 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D016738 |
Alagille Syndrome |
marker/mechanism |
|
| 21532573 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.30 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.47 | 15800139 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.79 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.79 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.77 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.16 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.47 | 15885639 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
3.29 | 16516891 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.27 | 11922910 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
4.76 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.77 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.47 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.57 | 15746008 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.61 | 14991843 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.17 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.02 | 15144691 18412241 16436596 16651633 16357521 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
5.50 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.50 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
5.50 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.50 | 17289903 19861407 12948864 14630087 16675129 18497071 17261762 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
5.50 | 19217205 16110121 15136595 16595493 16557594 18608205 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
5.50 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
5.50 | 16912660 17952589 15572757 17595753 15758505 15775269 17893378 17261762 17242785 16837676 17440819 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
5.50 | 17242785 20135344 17261762 18815881 16873071 18351453 18984771 19155303 18821012 15565566 20005174 19115204 19200415 19011961 19410462 19142967 16273361 19221464 18997820 17893378 20859285 20544844 21138602 19189210 18425577 15668708 20065188 19084267 21152245 11161223 19288272 16202921 19066611 19189212 19289846 18855134 16818667 18629630 17049068 19244106 19059307 19103187 20390343 19487384 17440819 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.50 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
tyrphostin AG 1478 |
4.64 | 12794006 |
MESH:D002057 |
Burns, Chemical |
|
Mechlorethamine |
5.92 | 9625245 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.15 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.35 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
12.58 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
12.58 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
12.58 | 16835633 |
MESH:D003528 |
Carcinoma, Adenoid Cystic |
marker/mechanism |
|
| 16762588 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.20 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.28 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
8.28 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.28 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
8.28 | 17088986 16332177 16799960 17045692 18930000 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.28 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.87 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
7.09 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.09 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.09 | 18986760 16757204 17066447 16280240 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.61 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.61 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.20 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.23 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
23.61 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
23.61 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
23.61 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
23.61 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
23.61 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
23.61 | 16192471 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.67 | 17160924 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.90 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.02 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.02 | 16919318 11677210 16105132 15861022 17681005 17110522 17333356 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.97 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.31 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
3.75 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.75 | 17169374 16510598 17018589 17725105 17016597 15001691 16340194 17287894 18772588 17172411 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
1.99 | 15289873 18509181 17255274 16282729 14970324 18383874 17094418 17695437 18448328 15148649 16391804 16524972 17594712 16303861 18949393 17454858 17016601 17401013 18288408 18802399 16331619 20501625 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
5.16 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 20055451 10048152 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.71 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.11 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.48 | 16733453 |
MESH:D003638 |
Deafness |
marker/mechanism |
|
| |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.06 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.90 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
6.85 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
6.85 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.85 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.52 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
13.52 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.52 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.24 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
8.24 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.24 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
8.24 | 17522070 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.53 | 11462148 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
5.16 | 9068938 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.67 | 18357618 |
MESH:D004487 |
Edema |
|
Raloxifene |
5.95 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.95 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.59 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
13.64 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
13.64 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
13.64 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.72 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.72 | 17893378 19155303 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.76 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.20 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.20 | 15173087 16481741 16337965 17638652 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.78 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
27.12 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
27.12 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
27.12 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
27.12 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
27.12 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
27.12 | 16917069 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.05 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.15 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.22 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.87 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.63 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
arsenite |
13.03 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.03 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.03 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.91 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
3.63 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
5.93 | 16357521 18412241 16651633 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
5.93 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.28 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.18 | 18337622 15162350 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
10.25 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.25 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.25 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.32 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.11 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.06 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.59 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.36 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.72 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.44 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 18606429 16959395 16354765 8697196 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.86 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
7.86 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.86 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.51 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.18 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.28 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
7.35 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.35 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.35 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.77 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.13 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.34 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.34 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
25.85 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
25.85 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
25.85 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
25.85 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
25.85 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
25.85 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.21 | 16973256 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.94 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.25 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
4.65 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.65 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.65 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.65 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
16.38 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
16.38 | 15890375 2125692 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
16.38 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
16.38 | 17045692 16603448 18383874 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
16.38 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.38 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
16.61 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
16.61 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
16.61 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
16.61 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
16.61 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
7.36 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
7.36 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
14.57 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
14.57 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
14.57 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.57 | 20064080 20464547 17053015 18816296 20869020 18569708 6695378 18520028 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
14.57 | 17703301 16271038 16019985 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
14.57 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
14.57 | 7750092 6695378 20970405 17909032 16337739 11893704 15390079 20512841 1399818 10545420 9230183 21163286 16271038 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
14.57 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.57 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.48 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
3.72 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.74 | 15375218 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.45 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.91 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
8.91 | 10767621 10838139 18041768 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
8.91 | 16827153 11731420 19196723 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.59 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.59 | 19453300 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
3.48 | 17992120 11746506 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.48 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.87 | 15990972 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.67 | 17943659 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.47 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.24 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.75 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.75 | 16757204 18986760 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.22 | 16497877 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
5.18 | 17962980 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.78 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.05 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.24 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.55 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
5.68 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.68 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.41 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.55 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
4.55 | 18600527 16928823 18239605 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.10 | 16707424 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.68 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
9.12 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
9.12 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.47 | 9884423 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.13 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.03 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.48 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.48 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
3.82 | 19446573 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.10 | 16003739 17160924 16651423 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.23 | 16436463 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
3.06 | 17217161 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.16 | 16049721 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.67 | 17160924 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.20 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.94 | 17823083 15758505 17893378 15579764 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.12 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.55 | 16929163 16500647 15113037 19003803 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.40 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.93 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
5.12 | 11026799 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.26 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.96 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.88 | 11222880 11896295 11399792 11118676 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
5.10 | 10903871 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.61 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.88 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.88 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.88 | 16220300 15731164 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.88 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.00 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.12 | 16882103 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
5.02 | 14606601 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.24 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.75 | 18722050 18286688 15538739 16160472 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
4.24 | 12210543 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 18990726 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.22 | 16849425 |
MESH:D012468 |
Salivary Gland Neoplasms |
marker/mechanism |
|
| 16762588 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.33 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
3.13 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
4.98 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
4.98 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.51 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.51 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.73 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.34 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.34 | 18567086 18396642 15786421 17522103 17498489 16424979 19015929 19084572 17172411 16951190 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
6.96 | 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
6.96 | 18726076 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
8.19 | 16403987 16517955 |
MESH:D020521 |
Stroke |
|
Raloxifene |
8.19 | 16837676 |
MESH:D013771 |
Tetralogy of Fallot |
marker/mechanism |
|
| |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.33 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.89 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
4.85 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.59 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.66 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.66 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.72 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.48 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
14.48 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
14.48 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
14.48 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
14.48 | 8653321 16712894 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.01 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.61 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.00 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.67 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.28 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.89 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.26 | 14671159 15869587 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.24 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.93 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.13 | 17120751 |